journal article·2021Open access

Multiparametric nanoparticle-induced toxicity readouts with single cell resolution in HepG2 multicellular tumour spheroids

Suainibhe Kelly, Maria H. Byrne, Susan J. Quinn, Jeremy C. Simpson

Nanoscale· Volume 13· Issue 41

Abstract

The use of nanomaterials as therapeutic delivery vehicles requires their careful pre-clinical evaluation. Of particular importance in this regard is measurement of cellular toxicity, ideally assessing multiple parameters in parallel from various relevant subcellular organelles. In recent years it has become evident that in vitro monolayer-grown cells do not always accurately predict any toxicity response seen in vivo, and so there is a need for more sophisticated in vitro cell models, employing a greater depth of characterisation. In this work we present an automated high-content screening microscopy approach for quantifying nanoparticle-induced toxicity in a three-dimensional multicellular tumour spheroid (MCTS) cell model. As a proof-of-principle, we perform a comparative toxicity profile study of carboxylate- versus amine-modified polystyrene nanoparticles in HepG2 spheroids. Following treatment with these nanoparticle types, we demonstrate that several hundred spheroids, of various sizes, can be morphologically profiled in a single well using automated high-content image analysis. This provides a first level of information about spheroid health in response to nanoparticle treatment. Using a range of fluorescent reporters assessing membrane permeability, lysosome function and mitochondrial activity, we also show that nanoparticle-induced toxicity information can be obtained from individual cells with subcellular resolution. Strikingly, our work demonstrates that individual cells do not all behave in a consistent manner within a spheroid structure after exposure to nanoparticles. This highlights the need for toxicity studies to not only assess an appropriate number of spheroids, but also the importance of extracting information at the subcellular level.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cell Image Analysis Techniques · 3D Printing in Biomedical Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cell Screening Laboratory, UCD School of Biology & Environmental Science, University College Dublin, Dublin 4, Ireland

UCD School of Chemistry, University College Dublin, Dublin 4, Ireland

Funding

Science Foundation Ireland · European Regional Development Fund

References (47)

Show source-provided references
1. Farjadian · Nanomedicine · 2019 · 14 · 9310.2217/nnm-2018-0120 ↗
2. Martins · Drug Delivery Transl. Res. · 2020 · 10 · 72610.1007/s13346-020-00743-2 ↗
3. Shi · Nat. Rev. Cancer · 2017 · 17 · 2010.1038/nrc.2016.108 ↗
4. Zhao · Polym. Chem. · 2017 · 8 · 331710.1039/C7PY00385D ↗
5. Wu · RSC Adv. · 2017 · 7 · 1243710.1039/C6RA27334C ↗
6. Liu · Biotechnol. Bioeng. · 2021 · 118 · 54210.1002/bit.27620 ↗
7. Lee · Biotechnol. Bioeng. · 2019 · 116 · 304110.1002/bit.27114 ↗
8. Sloan · Nat. Protoc. · 2018 · 13 · 206210.1038/s41596-018-0032-7 ↗
9. Lv · Oncol. Lett. · 2017 · 14 · 6999
10. Zhang · PLoS One · 2018 · 13 · e019401610.1371/journal.pone.0194016 ↗
11. Tsai · BMC Cancer · 2018 · 18 · 33510.1186/s12885-018-4238-4 ↗
12. Hurrell · Toxicol. In Vitro · 2018 · 50 · 8610.1016/j.tiv.2018.02.013 ↗
13. Lee · Small · 2009 · 5 · 121310.1002/smll.200801788 ↗
14. Ma · Mol. Imaging · 2012 · 11 · 48710.2310/7290.2012.00012 ↗
15. Elje · Nanomaterials · 2020 · 10 · E54510.3390/nano10030545 ↗
16. Kik · Environ. Pollut. · 2020 · 262 · 11429710.1016/j.envpol.2020.114297 ↗
17. Kyffin · Toxicol. In Vitro · 2018 · 48 · 26210.1016/j.tiv.2018.01.023 ↗
18. Ramaiahgari · Toxicol. Sci. · 2017 · 160 · 18910.1093/toxsci/kfx194 ↗
19. Katifelis · Artif. Cells, Nanomed., Biotechnol. · 2018 · 46 · S38910.1080/21691401.2018.1495645 ↗
20. Pellen-Mussi · J. Nanosci. Nanotechnol. · 2018 · 18 · 314810.1166/jnn.2018.14619 ↗
21. Dubiak-Szepietowska · Toxicology · 2016 · 370 · 6010.1016/j.tox.2016.09.012 ↗
22. Kroll · Arch. Toxicol. · 2012 · 86 · 112310.1007/s00204-012-0837-z ↗
23. Ong · PLoS One · 2014 · 9 · e9065010.1371/journal.pone.0090650 ↗
24. Guadagnini · Nanotoxicology · 2015 · 9 · 1310.3109/17435390.2013.829590 ↗
25. Andraos · Int. J. Toxicol. · 2020 · 39 · 39710.1177/1091581820938335 ↗
26. Mikhail · PLoS One · 2013 · 8 · e6263010.1371/journal.pone.0062630 ↗
27. Wang · Biomaterials · 2013 · 34 · 466710.1016/j.biomaterials.2013.03.008 ↗
28. Hornung · Anticancer Res. · 2016 · 36 · 3093
29. Oliveira · Int. J. Pharm. · 2016 · 512 · 29210.1016/j.ijpharm.2016.08.049 ↗
30. Lei · J. Thorac. Cardiovasc. Surg. · 2015 · 149 · 141710.1016/j.jtcvs.2015.02.020 ↗
31. Brayden · Drug Discovery Today · 2015 · 20 · 94210.1016/j.drudis.2015.04.001 ↗
32. Booij · SLAS Discovery · 2019 · 24 · 61510.1177/2472555219830087 ↗
33. Nürnberg · Front. Mol. Biosci. · 2020 · 7 · 2010.3389/fmolb.2020.00020 ↗
34. S. D.Collins , G.Yuen , T.Tu , M. A.Budzinska , K.Spring , K.Bryant and N. A.Shackel , in Hepatocellular Carcinoma , ed. J. E. E. Tirnitz-Parker , Codon Publications , Brisbane (AU) , 2019
35. Bevilacqua · Nanomaterials · 2021 · 11 · 78010.3390/nano11030780 ↗
36. Cutrona · Small · 2019 · 15 · e190203310.1002/smll.201902033 ↗
37. Vermeulen · Eur. J. Pharm. Biopharm. · 2018 · 129 · 18410.1016/j.ejpb.2018.05.034 ↗
38. Panarella · Sci. Rep. · 2016 · 6 · 2886510.1038/srep28865 ↗
39. Francia · Beilstein J. Nanotechnol. · 2020 · 11 · 33810.3762/bjnano.11.25 ↗
40. Joshi · Curr. Protoc. Toxicol. · 2019 · 79 · e6610.1002/cptx.66 ↗
41. Atale · J. Microsc. · 2014 · 255 · 710.1111/jmi.12133 ↗
42. García · Bioconjugate Chem. · 2019 · 30 · 24210.1021/acs.bioconjchem.8b00898 ↗
43. Darrigues · Sci. Rep. · 2020 · 10 · 336210.1038/s41598-020-59226-6 ↗
44. Bromma · Cancers · 2021 · 13 · 146510.3390/cancers13061465 ↗
45. Bexiga · Nanomedicine · 2014 · 9 · 165110.2217/nnm.13.151 ↗
46. Lee · Nanoscale · 2019 · 11 · 1998010.1039/C9NR04323C ↗
47. Lazzari · Eur. J. Pharm. Biopharm. · 2019 · 142 · 19510.1016/j.ejpb.2019.06.019 ↗